GlassScriptPhysician profile
Paul B Volpp
NPI 1225186232
$630.16
in general payments reported to CMS, 2019-2025
14 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.46 · 2020: $15.74 · 2021: $13.75 · 2022: $127 · 2023: $73.96 · 2024: $60.37 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $130.41 | 2025 | Ultomiris |
| Novocure INC. | $101.91 | 2019-2025 | Optune Gio, Optune |
| Siemens Medical Solutions USA, INC. | $82.17 | 2022-2025 | Bravos Afterloader System |
| Blue Earth Diagnostics | $57.70 | 2019-2023 | |
| Palette Life Sciences, INC. | $43.53 | 2022 | |
| Medtronic, INC. | $43.36 | 2022 | |
| Bioprotect Medical, INC. | $28.30 | 2025 | Bioprotect Balloon Implant System |
| Novartis Pharmaceuticals Corporation | $25.22 | 2025 | |
| Ge Healthcare | $24.92 | 2025 | |
| Cardinal Health 414 LLC | $22.41 | 2024 | |
| Gt Medical Technologies, INC | $20.61 | 2023 | Gammatile |
| Boston Scientific Corporation | $18.87 | 2019 | |
| Elekta, INC. | $17.00 | 2024 | Flexitron Hdr |
| Varian Medical Systems, INC. | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Volpp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.